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Abstract
Background: Suboptimal use of antibiotics is a driver of antimicrobial resistance (AMR). Clinical decision support systems
(CDSS) can assist prescribers with rapid access to up-to-date information. In low- and middle-income countries (LMIC), the
introduction of CDSS for antibiotic prescribing could have a measurable impact. However, interventions to implement them are
challenging because of cultural and structural constraints, and their adoption and sustainability in routine clinical care are often
limited. Preimplementation research is needed to ensure relevant adaptation and fit within the context of primary care in West
Africa.
Objective: This study examined the requirements for a CDSS adapted to the context of primary care in West Africa, to analyze
the barriers and facilitators of its implementation and adaptation, and to ensure co-designed solutions for its adaptation and
sustainable use.
Methods: We organized a workshop in Burkina Faso in June 2019 with 47 health care professionals representing 9 West African
countries and 6 medical specialties. The workshop began with a presentation of Antibioclic, a publicly funded CDSS for antibiotic
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prescribing in primary care that provides personalized antibiotic recommendations for 37 infectious diseases. Antibioclic is freely
available on the web and as a smartphone app (iOS, Android). The presentation was followed by a roundtable discussion and
completion of a questionnaire with open-ended questions by participants. Qualitative data were analyzed using thematic analysis.
Results: Most of the participants had access to a smartphone during their clinical consultations (35/47, 74%), but only 49%
(23/47) had access to a computer and none used CDSS for antibiotic prescribing. The participants considered that CDSS could
have a number of benefits including updating the knowledge of practitioners on antibiotic prescribing, improving clinical care
and reducing AMR, encouraging the establishment of national guidelines, and developing surveillance capabilities in primary
care. The most frequently mentioned contextual barrier to implementing a CDSS was the potential risk of increasing self-medication
in West Africa, where antibiotics can be bought without a prescription. The need for the CDSS to be tailored to the local
epidemiology of infectious diseases and AMR was highlighted along with the availability of diagnostic tests and antibiotics using
national guidelines where available. Participants endorsed co-design involving all stakeholders, including nurses, midwives, and
pharmacists, as central to any introduction of CDSS. A phased approach was suggested by initiating and evaluating CDSS at a
pilot site, followed by dissemination using professional networks and social media. The lack of widespread internet access and
computers could be circumvented by a mobile app with an offline mode.
Conclusions: Our study provides valuable information for the development and implementation of a CDSS for antibiotic
prescribing among primary care prescribers in LMICs and may, in turn, contribute to improving antibiotic use, clinical outcomes
and decreasing AMR.
(J Med Internet Res 2020;22(7):e17940) doi: 10.2196/17940
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Introduction
Antimicrobial Resistance
Antimicrobial resistance (AMR) is a global threat that affects
both high-income countries (HIC) and low- and middle-income
countries (LMIC). The drivers of AMR, including antibiotic
misuse, lack of infection prevention and control, and poor
sanitation, particularly affect LMICs [1,2]. Data suggest that
80% to 90% of all antibiotics used in humans are prescribed in
primary care [3]. Although antibiotic use has been increasing
over the last decade in LMICs [2,4], antibiotic prescribing
indicators in primary care for the African region deviate
significantly from the World Health Organization’s (WHO)
reference targets [5]. Deviations from existing guidelines on
antibiotic use, including delays and overuse, are linked both to
patients’ behavior and that of health care professionals [6,7].
There is thus a need to find interventions that could improve
antibiotic prescribing in primary care to respond to the global
threat of AMR.
Electronic Clinical Decision Support Systems
Electronic clinical decision support systems (CDSS) have been
devised to provide prescribers with rapid access to updated
information, which is required to make appropriate therapeutic
decisions [8]. CDSS can be split into CDSS providing
unsolicited information (eg, alerts for drug interactions) and
CDSS providing solicited information (eg, diagnostic support
systems). Computer representations of patient care guidelines
are among commonly used CDSS [9,10]. They allow the
prescriber to enter basic clinical information of a patient and
access the diagnostic or therapeutic guidelines adapted to the
patient’s unique situation. Machine learning CDSS that find
their own decision rules from the data are increasingly being
developed and may replace knowledge-based CDSS in which
human experts define the decision rules in the future [11]. CDSS
adapted in primary care have the potential to reduce overall
antibiotic use and improve the appropriateness of antibiotic
prescribing [12,13]. In LMICs, the introduction of such aids is
in the early stages of development [14], but it could have a
measurable impact within the context of sparse infectious
diseases specialists. Primary care prescribers in LMICs often
lack clinical practice guidelines adapted to their setting and do
not have access to antimicrobial stewardship programs [15].
Although they may not have access to health care information
systems, CDSS providing diagnostic guidance or easy access
to therapeutic guidelines may help them make the right decision
at the point-of-care [16]. Improving the adequacy of antibiotic
prescribing might, in turn, lead to better clinical outcomes and
decreased AMR. Moreover, CDSS have the potential to be
implemented in multiple health facilities without recruiting new
prescribers [17] and could optimize the utilization of resources
that are scarce in LMICs.
Implementation of Clinical Decisions Support System
in West Africa
Consequently, the development and implementation of CDSS
that fit into clinical work might be part of interventions to
mitigate against drivers of AMR in LMICs. However, the
adaptation of CDSS for antibiotic prescribing in routine clinical
care and their sustainability are often limited [10,18]. As is the
case with many innovations in health care, multiple CDSS have
been abandoned after their development and initial evaluation
because of multiple factors, including the lack of
preimplementation work [19]. Indeed, at the global level, the
situation analysis for AMR in human health often lack the
assessment of technological innovations [20]. Moreover, many
CDSS failed to demonstrate a clinical impact because of the
low uptake of the CDSS and poor adherence to the generated
advice [21,22]. According to the WHO, the adaptation of
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electronic CDSS is particularly low in LMICs [23]. Interventions
to implement CDSS are challenging because of cultural and
structural constraints, and these challenges are even more
pronounced in primary care where prescribing can be done by
a variety of health care professionals or when resources are
limited [14,24]. West Africa hosts about 381 million people
and includes 16 countries, among them some of the lowest
income countries in the world [25,26]. French-speaking West
African countries, including Benin, Burkina Faso, Cameroon,
Chad, Ivory Coast, Republic of Congo, Guinea, Mali, Niger,
Senegal, and Togo, were among the LMICs with the highest
increase in global antibiotic consumption between 2000 and
2015 [2]. As highlighted by the WHO, countries in the African
region are the least advanced regarding electronic and mobile
health [23].
Objectives
Before developing or implementing a CDSS for antibiotic
prescribing in West Africa, we need to understand the
contextual, structural, and behavioral determinants that will
facilitate or prevent the use of CDSS for antibiotic prescribing.
Our study aimed to examine the requirements for a CDSS
adapted to the context of primary care in West Africa and to
analyze the barriers and facilitators of its implementation and
adaptation by prescribers using qualitative methods during a
preimplementation workshop.
Methods
Study Design
Our aims were (1) to understand the potential benefits and risks
of a CDSS for antibiotic prescribing in primary care in West
Africa, (2) to analyze the barriers and facilitators of its
implementation, and (3) to ensure co-designed solutions for its
adaptation and sustainable use. To this end, we organized a
workshop with West African antibiotic prescribers that began
with a presentation of Antibioclic, a CDSS for antibiotic
prescribing currently widely used in France and freely available
on the web and as a smartphone app (further details below). We
chose to begin the workshop with an example of an existing
CDSS rather than with a theoretical description of a CDSS for
antibiotic prescribing. This strategy was considered by the
organizing team as the most promising to elicit reactions among
the participants. The main characteristics of a CDSS were
presented, and the organizers went through a number of clinical
scenarios on infectious diseases using Antibioclic. Then, the
organizers moderated a roundtable discussion with all the
participants. During this first-of-its-kind workshop, the
participants generated barriers and facilitators to the use of a
CDSS such as Antibioclic in West Africa and were asked to
hypothesize if its use could lead to benefits or risks, including
unexpected events. Participants were specifically asked to debate
the challenges in the implementation and adaptation of a CDSS
for antibiotic prescribing in West Africa and to co-design
solutions.
Antibioclic—An Example of a Clinical Decision
Support System for Antibiotic Prescribing
Antibioclic is a French CDSS for antibiotic prescribing in
primary care, [27] targeting 37 common infectious diseases,
freely available on the web and as a smartphone app on iOS
and Android. It was codeveloped by general practitioners,
specialists of infectious diseases, and engineers in 2011.
Clinicians can enter the diagnosis of a patient on the website or
app, they are then asked a few targeted questions (age group,
comorbidities, renal function, breastfeeding, and pregnancy).
Finally, they receive a tailored recommendation of antibiotic
regimen, dose, and duration according to French national
guidelines. Multimedia Appendices 1 and 2 describe how to
use Antibioclic respectively with slides or video in English.
Antibioclic was developed using a systematic method to
transform clinical practice guidelines from the French National
Authority for Health and the French Infectious Diseases Society
(SPILF) into decision trees in Antibioclic. Antibioclic is updated
frequently and modified as soon as a new guideline is published.
The number of Antibioclic users in France has steadily increased
over the past years from a median (IQR) of 414 (245-494) a
day in 2012 to 5365 (2891-5769) a day in 2018, without any
saturation to date (Multimedia Appendix 3). The smartphone
app has been downloaded 22,970 times on Android and 15,200
times on iOS. More details are described in a recent study [27].
Workshop Location and Participants
The 3-hour workshop to discuss the implementation and
adaptation of a CDSS for antibiotic prescribing in West Africa
was organized in Burkina Faso by 2 professors of infectious
diseases, 1 from Burkina Faso (AP) and 1 from France (FL).
To maximize participation and cost efficiency, the workshop
took place during the French-speaking university course
Antibiologie et Antibiothérapie en Afrique Subsaharienne
(Antibiotic therapy in Sub-Saharan Africa) organized in
Bobo-Dioulasso, Burkina Faso, on June 2019. This course lasts
5 weeks and is organized every year by the University Nazi
Boni of Bobo-Dioulasso and the University of Montpellier. The
course is open to West African health professionals working
on AMR or antibiotic therapy, whether in primary, secondary,
or tertiary care, with no selection among participants.
Attendance to the workshop was voluntary for the participants
of the course.
Electronic Questionnaire
After the roundtable discussion, an electronic questionnaire
with closed- and open-ended questions was given to each
participant (Multimedia Appendix 4). The questionnaire allowed
the collection of in-depth individual data on the implementation
and adaptation of a CDSS for antibiotic prescribing. The
questionnaire was codeveloped by a multidisciplinary team
including 6 members of the Antibioclic study team: infectious
diseases clinicians (AP and FL), a microbiologist (AO), public
health specialists (JB and GS) with experience in the West
African context, and an implementation science and knowledge
mobilization lecturer (RA). The first part collected demographic
characteristics and information regarding the use of electronic
tools for antibiotic prescribing. The second part displayed
open-ended questions about potential outcomes and users of a
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CDSS for antibiotic prescribing in West Africa and the
challenges of its implementation and adaptation.
Data Analysis
Data from the closed-ended questions of the questionnaire were
imported into R software version 3.2.4 (R Foundation for
Statistical Computing). Numerical data are presented as absolute
numbers, proportions, and median (IQR). The entire roundtable
discussion was audio recorded and transcribed verbatim by the
AMK France professional company. Data from the roundtable
discussion and open-ended questions were analyzed using
thematic analysis and were coded to identify key categories,
which were developed into themes using NVivo 12 software
(QSR International). The analysis of questionnaires and the
roundtable discussion supported cross-validation and
triangulation of the findings.
Ethical Considerations
Written consent was obtained from each participant. No
distinguishable personal information was recorded, and all the
data were analyzed anonymously. This survey was approved
by the research ethics committee of Centre Muraz (Health
Research Institute, Bobo-Dioulasso, Burkina Faso) and was
compliant with the European General Data Protection
Regulation.
Results
Participants
All 47 participants of the course, 19 women and 38 men with
a median (IQR) age of 31 (30-38) years, participated in the
workshop and completed the questionnaire (Table 1). Most of
the participants (35/47, 74%) were from Burkina Faso, but 8
other West African countries were represented. Approximately
half of the participants (24/47, 51%) worked in a university
hospital, whereas the others worked in general hospitals (14/47,
30%), public health institutes (4/47, 9%), dispensary (1/47, 2%),
private hospital (1/47, 2%), or pharmacies (1/47, 2%). The low
number of participants working as primary care prescribers may
be related to a more difficult access to university degrees. The
specialty of the participants was general practice (21/47, 45%),
microbiology (13/47, 28%), pharmacy (4/47, 9%),
anesthesiology and intensive care (3/47, 6%), infectious diseases
(2/47, 4%), and neurosurgery (2/47, 4%). Only 26% (12/47) of
participants, all in Burkina Faso, stated that they used national
guidelines to prescribe antibiotics. The others used French
guidelines (20/47, 43%), WHO guidelines (20/47, 43%), or
local hospital guidelines (4/47, 9%).
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Table 1. Demographic characteristics of participants (N=47).
ValuesCharacteristics
31 (30-38)Age (years), median (IQR)
Gender, n (%)
28 (60)Men
19 (40)Women
Country of practice, n (%)
35 (74)Burkina Faso
3 (6)Togo
2 (4)Senegal
2 (4)Mali
1 (2)Gabona
1 (2)Guinea
1 (2)Guinea-Bissau
1 (2)Ivory Coast
1 (2)Niger
Working structure, n (%)
24 (51)University hospital
14 (30)General hospital
4 (9)Public health institute
1 (2)Dispensary
1 (2)Private hospital
1 (2)Pharmacy
Medical specialty, n (%)
21 (45)General practice
13 (28)Microbiology
4 (9)Pharmacist
3 (6)Anesthesiology and intensive care
2 (4)Infectious diseases
2 (4)Neurosurgery
Guidelines used for clinical practice, n (%)
20 (43)French
20 (43)World Health Organization
12 (26)Nationalb
4 (9)Hospital
2 (4)American
2 (4)European
1 (2)Portuguese
aCentral Africa.
bThe 12 participants were from Burkina Faso.
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Current Use of Technology and Clinical Decision
Support Systems
Most of the participants (35/47, 74%) had a smartphone with
internet access during their clinical consultations, but less than
half (23/47, 49%) of the participants had access to a computer,
and 15% (7/47) of the participants had no access to any
electronic tools during their consultations. Most of the clinicians
did not use an electronic health record system (39/47, 83%) or
CDSS (36/47, 77%) for any clinical decision making during
their clinical consultations. The only CDSS mentioned by the
participants was a tool for basic medical calculations and a tool
that displays medical cards. No CDSS for antibiotic prescribing
(nor for any antimicrobial drug) was used by the participants
(Figure 1).
Figure 1. Current use of technology during consultation among participants. CDSS: clinical decision support systems.
Potential of a Clinical Decision Support Systems for
Antibiotic Prescribing
Most of the participants expected favorable outcomes from the
implementation of a CDSS for antibiotic prescribing in primary
care in their countries (Figure 2). They thought a CDSS was
likely to improve the quality of antibiotic prescribing (47/47,
100%), improve adherence to guidelines (47/47, 100%), improve
the management and care of patients (44/47, 94%), decrease
the number of medical errors (44/47, 94%), improve the volume
of antibiotic use (44/47, 94%), improve the duration of antibiotic
therapy (43/47, 91%), fight against AMR (43/47, 91%), increase
the medical knowledge of users (43/47, 91%), and save time
during consultation (38/47, 81%). Participants disagreed on the
fact that such a tool could strengthen the physician-patient
relationship (20/47, 43% judged it likely; 11/47, 23% unlikely;
and 16/47, 34% were neutral) or could lead to blind obedience
to electronic tools from prescribers (16/47, 34% judged it likely;
16/47, 34% unlikely; and 15/47, 32% were neutral).
J Med Internet Res 2020 | vol. 22 | iss. 7 | e17940 | p. 6https://www.jmir.org/2020/7/e17940
(page number not for citation purposes)
Peiffer-Smadja et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
Figure 2. Expected outcomes of a clinical decision support system for antibiotic prescribing. CDSS: clinical decision support systems.
During the roundtable discussion and through the open-ended
questions, the participants identified a number of consequences
of a CDSS on a wider scale. Participants underlined the lack of
antimicrobial stewardship teams in West Africa. They
hypothesized that a CDSS could help many isolated structures
to have access to antibiotic prescribing recommendations and
could relieve existing antimicrobial stewardship teams of simple
antibiotic prescribing advice and let them focus on complex
cases. One participant noted that a CDSS could be used to
increase surveillance capability in primary care. Indeed, its use
could be monitored and lead to reports on the incidence of
infectious diseases and the rate of antibiotic prescriptions. The
participants agreed that this is particularly important in West
African countries where epidemiological data are scarce. The
use of French guidelines was not seen as a barrier to a CDSS.
Indeed, most of the participants declared that they did not have
national guidelines to prescribe antibiotics in their country.
However, the participants pointed out that a successful CDSS
could have a positive impact in encouraging national societies
to develop guidelines that could then be integrated into the
CDSS. More broadly, they agreed that this CDSS could help to
increase the awareness of health professionals on the importance
of appropriate prescribing and the risks of AMR. The
participants also agreed that a CDSS could be used in the initial
training and continuous medical education of health
professionals by updating antibiotic prescribing knowledge:
If you use it continually, you certainly update your
knowledge. [General practitioner in Burkina Faso]
Regarding the scope of a CDSS for antibiotic prescribing, the
participants stated that it could have a positive impact on the
management of urinary tract infections (84%); skin and soft
tissue infections (84%); gastrointestinal tract infections (83%);
genital infections (80%); pneumonia (77%); meningitis (70%);
ear, nose, and throat infections (70%); dental infections (67%);
and surgical site infections (61%). The participants identified
a wide diversity of potential users of a CDSS for antibiotic
prescribing in West Africa, including general practitioners,
infectious diseases specialists, physicians in other specialties,
pharmacists, nurses, clinical microbiologists, and midwives.
Challenges
The participants identified a number of challenges and proposed
a number of solutions for the adaptation of a CDSS for antibiotic
prescribing in a West African setting (Table 2), and these are
grouped by system level.
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Table 2. Challenges and potential solutions for the development and implementation of a clinical decision support system in the West African context.
Potential solutionsChallenges to CDSS implementationChallenges to CDSSa developmentLevel
Country level • Encouraging studies to better analyze the
local and regional epidemiology
• N/Ab• Scarce epidemiological data on
the prevalence and incidence
of infectious diseases and the • Developing and updating the CDSS accord-
ing to local and regional epidemiology regard-level of antimicrobial resis-
tance ing infectious diseases, microbiology, and
antimicrobial resistance
• Including tuberculosis and common parasitic
diseases
• The CDSS should follow local, regional, and
national guidelines where they exist. If they
• N/A• Lack of national guidelines
do not, the CDSS could follow French or
WHOc guidelines as they are used by most
participants
• The CDSS should be developed for the sub-
continent of West Africa and then could be
further adapted to each country
• To easily adapt the CDSS to local and nation-
al guidelines, the programming and code of
the CDSS should be in open access
• Adapting the suggestions to locally available
diagnostic tests and antibiotics by working
• N/A• Limited availability of diagnos-
tic tests and antibiotics
with national scientific societies
Health care
structure level
• Development of an offline mode of the
CDSS
• Lack of internet access and informa-
tion technology infrastructure
• N/A
• Development of a mobile version on iOS and
Android
• Increasing the availability of computers and
internet access in West Africa
• Pilot testing of the CDSS in a primary care
structure linked to an academic hospital be-
• Independently operating and geograph-
ically isolated health structures such
• N/A
fore disseminating the tool to other healthas dispensaries
structures
• Field communication with primary care pre-
scribers
• Using the network of the Ministry of Health
Individual lev-
el: clinicians
and patients
• Co-designing the CDSS with general practi-
tioners, nurses, midwives, microbiologists,
dentists, and pharmacists
• N/A• Diversity of training needs for
primary care prescribers
• Allowing for different modules of access for
health professionals to meet the different in-
formation needs
• Dedicated training for primary care pre-
scribers Communicating through scientific
• Lack of awareness and training about
CDSS
• N/A
and professional societies, using traditional
and social media
• Involving all the stakeholders, including
health authorities, the Ministry of Health,
and the media
• Limiting access to registered health profes-
sionals (disagreement between participants)
• Risk of increasing self-treatment with
antibiotics as they are available with-
• N/A
out prescription in most West African • Regulating access to antibiotics without pre-
scriptioncountries
• Improving the training of prescribers about
antibiotic prescribing
• Risk of deskilling and dependency of
prescribers
• N/A
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Potential solutionsChallenges to CDSS implementationChallenges to CDSSa developmentLevel
• Education of patients about the need to use
reference books or electronic sources to
provide the best care
• Ensuring the independence of the tool from
pharmaceutical companies
• Risk to lose patients’ confidence by
following the advice of an electronic
tool
• N/A
aCDSS: clinical decisions support system.
bN/A: not applicable.
cWHO: World Health Organization.
Country Level
At the country level, the participants pointed out the scarcity of
epidemiological data in West African countries, the difference
between epidemiology of diseases in HICs and LMICs, the lack
of national guidelines, and the limited availability of diagnostic
tests and antibiotics. To produce computer-interpretable clinical
guidelines, CDSS developers need to have access to clinical
practice guidelines. For countries where national guidelines for
infectious diseases management do not exist, the participants
first suggested the development of a CDSS based on French or
WHO guidelines to encourage the establishment of national
guidelines. To address the specific needs of primary care
prescribers in West Africa, the CDSS should not only target the
management of common bacterial diseases but also the
management of parasitic diseases and tuberculosis. Participants
stressed the importance of tailoring the CDSS to local capacity
and infrastructure, such as resource availability and antibiotics,
with the help of national scientific societies.
Health Care Structure Level
The first challenge at the organization level was the lack of
internet access and information technology (IT) infrastructure.
Taking into account the wide availability of smartphones with
internet access, the participants highlighted major opportunities
through the development of mobile phone versions of CDSS
(on iOS and Android) with an offline mode. The second
challenge was the important number of independently operating
and geographically isolated health structures, such as
dispensaries, in the West African health system. To reach these
structures, participants suggested the involvement of relevant
stakeholders, including health authorities, the Ministry of Health,
scientific societies, the media, and opinion leaders, using
traditional and social media:
It is important to use the traditional networks of the
Ministry of Health where information goes down
hierarchically but also social media that are more
and more used. [Physician in a university hospital,
Burkina Faso]
The organization of a phased approach was suggested by
initiating and evaluating CDSS in a pilot primary care structure
linked to an academic hospital followed by dissemination to
other health structures:
You have to show people that it's used by people like
them starting with a pilot test site. [Physician in a
general hospital, Burkina Faso]
Individual Level: Clinicians and Patients
The diversity of primary care prescribers who have different
levels of decision support needs was identified as a challenge
to developing effective CDSS. A physician working in a general
hospital stated that in West Africa “nurses see a lot of patients,
certainly more than physicians” highlighting the need to
codevelop the CDSS with primary care health care professionals
who frequently prescribe antibiotics, such as general
practitioners, nurses, midwives, microbiologists, dentists, and
pharmacists. The implementation of a CDSS in West Africa
should take into account the lack of widespread knowledge on
the use of CDSS by organizing training sessions with primary
care prescribers. One participant said that some health care
professionals or patients could be refractory to new technologies,
but this was not considered a major barrier by the other
participants. The participants identified a number of facilitators
for the adaptation of a CDSS by primary care prescribers and
patients, including the independence of the tool from
pharmaceutical companies, codevelopment with users, free
access to the CDSS, and good usability.
The most discussed unexpected consequence was that an open
access CDSS such as Antibioclic could amplify self-medication
of antibiotics due to availability without prescription:
My point of view is really mixed. This represents an
undeniable progress for antibiotic prescribing but in
the context of our country, there is a non-negligible
risk of self-medication by non-healthcare
professionals. [General practitioner, Burkina Faso]
A very good tool for the treatment of infections but
which could be dangerous in the southern countries
because of self-medication and the accessibility of
antibiotics without prescription. [Physician in a
university hospital, Burkina Faso]
In this context, the CDSS may be used as a substitute for expert
health care opinion. However, some participants highlighted
the fact that much information is already available on the web
and that Antibioclic is already available, including in Burkina
Faso, with no reported use by patients. In fact, there was
uncertainty regarding if implementing a CDSS in West Africa
would amplify the phenomenon of self-medication or would
help by providing a reliable source to patients who would want
to self-medicate anyway:
Some patients will buy antibiotics without
prescription, with or without the tool. [General
practitioner, Burkina Faso]
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On the contrary, if patients have access to national
recommendations, this reinforces and this even
facilitates your message. [Professor in a university
hospital, Burkina Faso]
A consensus emerged that the best solution is to increase efforts
to limit access to antibiotics without prescription.
Discussion
Principal Findings
We conducted a preimplementation workshop with West African
health professionals to examine the requirements for a CDSS
adapted to the context of primary care in their countries. The
use of CDSS for antibiotic prescribing (and other clinical
decisions, in fact) is currently missing, but the importance and
need for such tools to support antibiotic prescribing in primary
care were stressed by all participants. Regarding the
implementation of a CDSS in primary care, the participants
encouraged a procedure of co-designing the tool with health
professionals and stakeholders involved in antibiotic prescribing
and initiation via a primary care pilot site, which is linked to an
academic hospital (Figure 3). The diffusion of the CDSS would
be more successful if supported by networks of medical
specialists and the Ministry of Health but should also take
advantage of social media because of its high use among health
care professionals. The lack of widespread internet access and
computers during consultation was a barrier to the use of the
CDSS, but it could be circumvented by the development of a
mobile app with an offline mode. The CDSS should be tailored
to the local epidemiology of infectious diseases and AMR, and
the high prevalence of malaria, tuberculosis, and HIV in West
Africa should be taken into account when developing the CDSS
[28]. The availability of diagnostic tests and antibiotics may
differ between West African countries and may vary over time,
requiring frequent updates of the CDSS.
Figure 3. Key steps for the development and implementation of a clinical decision support systems for antibiotic prescription in low- and middle-income
countries. AMR: antimicrobial resistance; CDSS: clinical decision support systems.
The participants pointed out the potential risk of self-medication
in countries in which antibiotics can be bought with no
prescription. Such a risk should certainly be anticipated and
monitored, but most of the participants did not think that the
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CDSS should have restricted access. On the contrary, some
participants thought that a CDSS could provide an opportunity
to strengthen the education of the general public about antibiotic
prescribing and AMR. Development and implementation of a
CDSS was seen to be associated with a number of benefits
related to improving clinical care and reducing AMR and also
to strengthening and updating practitioners’ knowledge of
antibiotic prescribing recommendations, encouraging the
development of national guidelines, and developing surveillance
capabilities in primary care. Indeed, the implementation of a
CDSS for antibiotic prescribing could be coupled with measures
that allow an increase in the capability of surveillance of
antibiotic use. Examples include real-time monitoring of
requests expressed on the platform and extracting reports about
antibiotic use [27,29]. Moreover, the implementation of a CDSS
in the community could have implications beyond antibiotic
prescribing in primary care. Indeed, primary care is the gateway
to secondary and tertiary care, and AMR in primary care
circulates in the whole health system [30].
Comparison With Prior Work
The lack of preimplementation and co-design work concerning
the assessment of CDSS for antibiotic prescribing has been
reported in recent reviews [10,31]. More broadly, research on
the implementation strategies for CDSS in primary care is
lacking [32]. A qualitative design involving 33 face-to-face
interviews with general practitioners has been used to codevelop
computer-delivered interventions to promote guidelines for
antibiotic prescribing in the United Kingdom. The authors
focused on the technical development of prompts and the
determinants of their acceptability but did not study the
implementation of the CDSS in clinical practice [33].
Postimplementation research found that the key factor for the
use of this CDSS by general practitioners in primary care was
their awareness of the implementation of the system within their
practice [22]. The lack of end-user engagement with
implementation and the rigidity of the guidelines incorporated
in the prompts were barriers to the effective adaptation of the
system, stressing the importance of a systematic and
theoretically informed process of implementation for CDSS
[34]. The nonadaptation, abandonment, scale-up, spread, and
sustainability framework has been developed to support the
implementation of technological innovations in health and social
care [19]. It lists challenges in 7 domains: the condition or
illness, the technology, the value proposition, the adopter system
(comprising professional staff, patient, and lay caregivers), the
organization(s), the wider (institutional and societal) context,
and the interaction and mutual adaptation between all these
domains over time.
Few studies have focused on CDSS for the management of
infectious diseases in LMICs and in particular in West Africa.
A recent review identified 6 CDSS for the management of
febrile children in primary care in LMICs [35]. In a pilot
cluster-randomized controlled study, the clinical algorithm for
management of childhood illness available on smartphones
(e-ALMANACH) increased the number of children screened
for red flags and decreased antibiotic prescription in Tanzania
[36]. This result was confirmed in another controlled study in
which the use of e-ALMANACH to manage children improved
clinical outcomes and reduced antibiotic prescription by 80%
[37]. Electronic point-of-care tool, an electronic algorithm using
point-of-care testing results including C-reactive protein and
procalcitonin, was shown to improve the clinical outcomes of
children with febrile illnesses as compared with the
e-ALMANACH CDSS [38,39]. Another study described a
protocol for the implementation on a large scale in Burkina Faso
of an electronic tool for integrated management of childhood
illnesses [40]. The results of this trial have not been published
yet. In general, few data are available on the adaptation and
sustainability of such interventions. One team analyzed the
implementation cost of a CDSS for antenatal and delivery care
and found that most of the cost resulted from the recruitment
and training of nurses and midwives using the CDSS and from
buying laptops [41]. A CDSS that is easily used by health care
professionals and is available as a free mobile app could lead
to a decreased implementation cost. A study in Burkina Faso
confirmed a positive attitude toward electronic decision support
systems and the need for simplicity and good usability of the
tool. They found similar barriers, such as the lack of
infrastructure and IT systems and the limited availability of
drugs and diagnostic tests [42]. The development of CDSS in
LMICs could be facilitated by the development of mobile health
[43] and by sharing open-source codes [44]; however, other
challenges remain: countries often have to buy a back-office or
another hosting solution and have to pay for the maintenance
of the server [45,46]. These costs, if not anticipated, can limit
the sustainability of CDSS.
Limitations
The participants stressed the diversity of prescribers and health
structures in West Africa that must be taken into account when
codeveloping the CDSS. However, most of the participants in
our workshop were physicians specialized in general practice
working in Burkina Faso university hospitals. This bias was
related to our recruitment of participants via a university degree
organized by French and Burkina Faso universities. We, thus,
need to involve more primary care prescribers such as nurse
prescribers, midwives, and physicians working in dispensaries
to allow for a broader view of primary care antibiotic
prescribing. Indeed, prescribing habits may vary between
professional groups [47,48], and we would like to capture
potential differences among prescribers concerning the use,
needs, and expectations regarding CDSS for antibiotic
prescribing.
To open the discussion, we decided to provide an example of
a currently used CDSS. Indeed, as we anticipated that most of
the participants had no experience using electronic decision
support systems for antibiotic prescribing, we wanted to show
them an existing CDSS and collect opinions. This approach was
likely to influence the answers of participants and the discussion
during the roundtable discussions. However, we think that the
barriers and facilitators identified in the study are not limited
to Antibioclic. Indeed, the contextual barriers that have been
found have been described in other studies. Nonprescription
dispensing of antibiotics in the community has been widely
described both in LMICs [49,50] and in HICs [51]. In a recent
review, the authors did not find any clinical practice guideline
applicable to prehospital care in LMICs among 276 guidelines
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[15]. For countries where national guidelines for the
management of infectious diseases do not exist, the participants
suggested the development of a CDSS first based on French or
WHO guidelines to encourage the establishment of national
guidelines.
The governance system and public health priorities could be
important additional factors that need to be studied in West
Africa before the implementation of a CDSS. Work has been
done in European countries about governance to address AMR
[52], and relevant frameworks for assessing this important factor
exist [20,53]. However, the analysis and governance frameworks
for antibiotic prescribing often lack the assessment of
technological innovation, such as electronic decision support.
Including CDSS in the national action plan as in the United
Kingdom’s 2019-2024 national plan that targets to “be able to
report on the percentage of prescriptions supported by a
diagnostic test or decision support tool by 2024” is probably an
important step toward the development and implementation of
support systems [54]. We are not aware of Western African
national action plans mentioning the development and use of
CDSS.
Conclusions
Preimplementation research is needed to ensure that CDSS are
adapted to the context in which they are deployed. Our study
provided valuable information to develop and implement a
CDSS for antibiotic prescribing among primary care prescribers
in LMICs. We plan to organize workshops to co-design a CDSS
tailored to the context of primary care in West Africa.
Optimizing the use of antibiotics in primary care may have
beneficial consequences for the entire health system and can
contribute to limiting the spread of AMR. Most of the barriers
and facilitators that we identified may easily relate to a broad
spectrum of CDSS, including systems for clinical decisions
other than antibiotic prescribing.
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